文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Sinensetin suppresses breast cancer cell progression via Wnt/β-catenin pathway inhibition.

作者信息

Zhu Shengqian, Meng Lifei, Wei Peng, Gu Guowen, Duan Keli

机构信息

Department of Plastic and Reconstructive Surgery, The First Affiliated Hospital of Ningbo University, Ningbo, China.

Department of Thoracic Surgery, The First Affiliated Hospital of Ningbo University, Ningbo, China.

出版信息

Transl Cancer Res. 2024 Jan 31;13(1):348-362. doi: 10.21037/tcr-23-1317. Epub 2024 Jan 12.


DOI:10.21037/tcr-23-1317
PMID:38410229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10894327/
Abstract

BACKGROUND: Although there are many treatments for breast cancer, such as surgery, radiotherapy, chemotherapy, estrogen receptor antagonists, immune checkpoint inhibitors and so on. However, safer and more effective therapeutic drugs for breast cancer are needed. Sinensetin, a safer therapeutic drugs, come from citrus species and medicinal plants used in traditional medicine, while its role and underlying mechanism in breast cancer remain unclear. Our study aimed to investigate the role and mechanism of sinensetin in breast cancer. METHODS: Cell Counting Kit-8 (CCK-8) was used to determine the safe concentration of sinensetin in MCF-10A, MCF7 and MDA-MB-231 cells; 120 μM sinensetin was used in subsequent experiments. Real time polymerase chain reaction (RT-PCR), Western blotting, Terminal Deoxynucleotidyl Transferase mediated dUTP Nick-End Labeling (TUNEL) apoptosis assay, Transwell invasion assay and Clone formation assay were used in this study to determine cell viability, mRNA expression, protein levels, apoptosis, proliferation, invasion and so on. RESULTS: Herein, our results showed that 120 μM sinensetin suppressed the cell viability and promoted apoptosis of MCF7 and MDA-MB-231 cells. Treatment with 120 µM sinensetin for 24 h showed no significant toxicity to normal mammary cells; 120 μM sinensetin decreased cell proliferation, invasion, and epithelial-mesenchymal transition (EMT), and downregulated β-catenin, lymphatic enhancing factor 1 (LEF1), T-cell factor (TCF) 1/TCF7, and TCF3/TCF7L1 expression in MCF7 and MDA-MB-231 cells. The Wnt agonist SKL2001 reversed the inhibitory effect of sinensetin on cell survival, metastasis, and EMT. Sinensetin-induced downregulation of β-catenin, LEF1, and TCF1/TCF7 expression were upregulated by SKL2001 in MCF7 and MDA-MB-231 cells. CONCLUSIONS: In summary, sinensetin suppressed the metastasis of breast cancer cell via inhibition of Wnt/β-catenin pathway and there were no adverse effects on normal breast cells. Our study confirmed the role of sinensetin in breast cancer cells and provided a better understanding of the underlying mechanism.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2208/10894327/b18e879587d6/tcr-13-01-348-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2208/10894327/ff44379407c4/tcr-13-01-348-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2208/10894327/78d363638721/tcr-13-01-348-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2208/10894327/d8a87976121f/tcr-13-01-348-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2208/10894327/10aae37bb421/tcr-13-01-348-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2208/10894327/b18e879587d6/tcr-13-01-348-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2208/10894327/ff44379407c4/tcr-13-01-348-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2208/10894327/78d363638721/tcr-13-01-348-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2208/10894327/d8a87976121f/tcr-13-01-348-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2208/10894327/10aae37bb421/tcr-13-01-348-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2208/10894327/b18e879587d6/tcr-13-01-348-f5.jpg

相似文献

[1]
Sinensetin suppresses breast cancer cell progression via Wnt/β-catenin pathway inhibition.

Transl Cancer Res. 2024-1-31

[2]
Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.

Drug Des Devel Ther. 2016-4-18

[3]
FL118, a novel camptothecin analogue, suppressed migration and invasion of human breast cancer cells by inhibiting epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.

Biosci Trends. 2018

[4]
Wnt/β-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells.

Int J Clin Exp Pathol. 2015-10-1

[5]
The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.

Drug Des Devel Ther. 2015-2-17

[6]
Apatinib Inhibits Stem Properties and Malignant Biological Behaviors of Breast Cancer Stem Cells by Blocking Wnt/β-catenin Signal Pathway through Downregulating LncRNA ROR.

Anticancer Agents Med Chem. 2022

[7]
In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.

Oncotarget. 2017-2-28

[8]
RBBP4 promotes colon cancer malignant progression regulating Wnt/β-catenin pathway.

World J Gastroenterol. 2020-9-21

[9]
Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis.

J Exp Clin Cancer Res. 2019-5-8

[10]
γ-Tocotrienol reversal of epithelial-to-mesenchymal transition in human breast cancer cells is associated with inhibition of canonical Wnt signalling.

Cell Prolif. 2016-8

引用本文的文献

[1]
Risk scoring model for lung adenocarcinoma based on PD-L1 related signature reveals prognostic predictability and correlation with tumor immune microenvironment genes was constructed.

Front Immunol. 2025-6-11

[2]
Role of PARP Inhibitors: A New Hope for Breast Cancer Therapy.

Int J Mol Sci. 2025-3-19

[3]
Citrus flavonoids for overcoming breast cancer resistance to methotrexate: identification of potential targets of nobiletin and sinensetin.

Discov Oncol. 2025-3-20

[4]
LncRNA TCL6 regulates miR-876-5p/MYL2 axis to suppress breast cancer progression.

Transl Oncol. 2025-3

[5]
FNDC1 Facilitates Proliferation, Migration, and Invasion of Breast Cancer Cells Through Modulating Wnt/β-Catenin Pathway.

Biochem Genet. 2024-12-13

[6]
Flavonoids of Euphorbia hirta inhibit inflammatory mechanisms via Nrf2 and NF-κB pathways.

Cell Biochem Biophys. 2025-3

[7]
A-to-I-edited miR-1251-5p restrains tumor growth and metastasis in lung adenocarcinoma through regulating TCF7-mediated Wnt signaling pathway.

Discov Oncol. 2024-10-24

[8]
Sinensetin Inhibits Angiogenesis in Lung Adenocarcinoma via the miR-374c-5p/VEGF-A/VEGFR-2/AKT Axis.

Cell Biochem Biophys. 2024-9

本文引用的文献

[1]
Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer.

Front Pharmacol. 2023-9-28

[2]
The Role of MicroRNAs in Breast Cancer and the Challenges of Their Clinical Application.

Diagnostics (Basel). 2023-9-28

[3]
The Evolving Pathways of the Efficacy of and Resistance to CDK4/6 Inhibitors in Breast Cancer.

Cancers (Basel). 2023-10-2

[4]
Estrogen Receptor Signaling in Breast Cancer.

Cancers (Basel). 2023-9-23

[5]
Cell plasticity modulation by flavonoids in resistant breast carcinoma targeting the nuclear factor kappa B signaling.

Cancer Metastasis Rev. 2024-3

[6]
The King is in the altogether: Radiation therapy after oncoplastic breast surgery.

Breast. 2023-12

[7]
Surgical options for patients with early-stage breast cancer and pathogenic germline variants: an oncologist perspectives.

Front Oncol. 2023-9-14

[8]
Progress and prospect: Biosynthesis of plant natural products based on plant chassis.

Biotechnol Adv. 2023-12

[9]
Natural products as a source of new anticancer chemotypes.

Expert Opin Ther Pat. 2023-11

[10]
The role of immune checkpoint inhibition in triple negative breast cancer.

Expert Rev Anticancer Ther. 2023

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索